Literature DB >> 9086406

Enhanced vascularization in a microporous polyurethane graft impregnated with basic fibroblast growth factor and heparin.

K Doi1, T Matsuda.   

Abstract

Rapid and controlled neoarterial regeneration via perianastomotic as well as transmural tissue ingrowth is critical to patency of implanted small-caliber artificial vascular grafts. Microporous polyurethane (PU) grafts (inner diameter, 1.5 mm; wall thickness, 100 microns; length, 20 mm; pore size, 100 microns), fabricated using an excimer laser ablation technique, were coated with a mixed solution of photoreactive gelatin, basic fibroblast factor (bFGF), and heparin, and were photocured by ultraviolet irradiation. Control grafts were treated with only photoreactive gelatin. An in vitro study showed that coimmobilization of bFGF and heparin (bFGF/heparin) in a crosslinked gelatin gel significantly enhances proliferation of endothelial cells. The bFGF/heparin-impregnated grafts (n = 6) and nonimpregnated (control) grafts (n = 9) were implanted in aortas of rats for 4 weeks. All the implanted grafts were patent, but there was a marked difference in the extent of neoarterial regeneration between the two groups. Irrespective of group, endothelialization proceeded from anastomotic sites and little occurrence of transmural capillary ingrowth was observed. The extent of endothelialization was much greater for bFGF/heparin-immobilized grafts than that for controls. In subendothelial tissues for the impregnated group, a significantly profound peripheral transmural tissue ingrowth including recruits of smooth muscle cells and fibroblasts from adjacent native tissue was observed near anastomotic sites; subendothelial tissue regeneration was noticed at the midportions of the grafts. However, only a fibrin layer was formed on control grafts. Thus, coimmobilization of bFGF and heparin significantly accelerated neoarterial regeneration via both perianastomotic and transmural tissue ingrowth. The former was more extensive than the latter.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9086406     DOI: 10.1002/(sici)1097-4636(19970305)34:3<361::aid-jbm11>3.0.co;2-j

Source DB:  PubMed          Journal:  J Biomed Mater Res        ISSN: 0021-9304


  5 in total

1.  Sustaining neovascularization of a scaffold through staged release of vascular endothelial growth factor-A and platelet-derived growth factor-BB.

Authors:  Neil H Davies; Christian Schmidt; Deon Bezuidenhout; Peter Zilla
Journal:  Tissue Eng Part A       Date:  2011-09-06       Impact factor: 3.845

Review 2.  Biomaterials for vascular tissue engineering.

Authors:  Swathi Ravi; Elliot L Chaikof
Journal:  Regen Med       Date:  2010-01       Impact factor: 3.806

Review 3.  Polymeric materials for tissue engineering of arterial substitutes.

Authors:  Swathi Ravi; Zheng Qu; Elliot L Chaikof
Journal:  Vascular       Date:  2009 May-Jun       Impact factor: 1.285

Review 4.  Targeted Delivery of Bioactive Molecules for Vascular Intervention and Tissue Engineering.

Authors:  Hannah A Strobel; Elisabet I Qendro; Eben Alsberg; Marsha W Rolle
Journal:  Front Pharmacol       Date:  2018-11-21       Impact factor: 5.810

5.  Gelatin-modified polyurethanes for soft tissue scaffold.

Authors:  Justyna Kucińska-Lipka; Iga Gubańska; Helena Janik
Journal:  ScientificWorldJournal       Date:  2013-11-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.